Cogent Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Cogent Biosciences, Inc.‘s stocks are currently a part of 67 hedge funds’ portfolios, which represents 25.22% of the total amount of its stocks outstanding. This makes up a total of 14.81M shares of Cogent Biosciences, Inc.. Compared to the previous quarter, the number fell by -80.21% or -60.05M shares fewer. As for the holding position changes, 29.85% (20) of current hedge fund investors increased the number of shares held, 37.31% (25) of current holders sold a part of the shares held, and 13.43% (9) closed the holdings completely. 8 hedge funds are new holders of Cogent Biosciences, Inc. stock in Q1 2023, it is 11.94% of total holders.
Hedge funds holding Cogent Biosciences (Q3 2016 – Q1 2023)
| Q3 2016 | 35 |
|---|---|
| Q4 2016 | 44 |
| Q1 2017 | 49 |
| Q2 2017 | 49 |
| Q3 2017 | 50 |
| Q4 2017 | 53 |
| Q1 2018 | 45 |
| Q2 2018 | 2 |
| Q3 2018 | 0 |
| Q3 2020 | 1 |
| Q4 2020 | 68 |
| Q1 2021 | 67 |
| Q2 2021 | 67 |
| Q3 2021 | 73 |
| Q4 2021 | 80 |
| Q1 2022 | 85 |
| Q2 2022 | 108 |
| Q3 2022 | 131 |
| Q4 2022 | 133 |
| Q1 2023 | 67 |
Hedge funds changes in Cogent Biosciences positions (Q3 2016 – Q1 2023)
| Q3 2016 | 35 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2016 | 14 | 12 | 9 | 5 | 4 |
| Q1 2017 | 14 | 13 | 17 | 5 | 0 |
| Q2 2017 | 8 | 26 | 8 | 8 | -1 |
| Q3 2017 | 6 | 15 | 17 | 5 | 7 |
| Q4 2017 | 12 | 17 | 13 | 9 | 2 |
| Q1 2018 | 7 | 25 | 5 | 15 | -7 |
| Q2 2018 | 0 | 0 | 0 | 43 | -41 |
| Q3 2018 | 0 | 0 | 0 | 2 | -2 |
| Q3 2020 | 1 | 0 | 0 | 0 | 0 |
| Q4 2020 | 68 | 0 | 0 | 1 | -1 |
| Q1 2021 | 17 | 27 | 10 | 17 | -4 |
| Q2 2021 | 18 | 18 | 10 | 18 | 3 |
| Q3 2021 | 15 | 17 | 19 | 8 | 14 |
| Q4 2021 | 20 | 19 | 23 | 13 | 5 |
| Q1 2022 | 15 | 18 | 30 | 9 | 13 |
| Q2 2022 | 37 | 43 | 18 | 12 | -2 |
| Q3 2022 | 34 | 44 | 36 | 12 | 5 |
| Q4 2022 | 22 | 52 | 36 | 20 | 3 |
| Q1 2023 | 8 | 20 | 25 | 9 | 5 |
Hedge funds changes in Cogent Biosciences stock options (Q3 2016 – Q1 2023)
| Q3 2016 | 1,306,000 | 226,000 |
|---|---|---|
| Q4 2016 | 59,000 | 149,000 |
| Q1 2017 | 90,000 | 1,377,000 |
| Q2 2017 | 505,000 | 2,025,000 |
| Q3 2017 | 257,000 | 615,000 |
| Q4 2017 | 114,000 | 467,000 |
| Q1 2018 | 520,000 | 546,000 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 3,000 | 0 |
| Q2 2022 | 2,117,000 | 2,354,000 |
| Q3 2022 | 1,416,000 | 308,000 |
| Q4 2022 | 703,912 | 13,872 |
| Q1 2023 | 9,000 | 14,000 |